Publications by authors named "Richard Heng"

Claim this Profile
D
Documenting Disclosure: Limited Reporting of Generative AI Usage in Radiology Research Manuscripts.
D Jonah Barrett, Richard Heng, Jordan D Perchik

Acad Radiol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A disorder-related variant (E420K) of a PP2A-regulatory subunit (PPP2R5D) causes constitutively active AKT-mTOR signaling and uncoordinated cell growth.
Cinta M Papke, Kali A Smolen, Mark R Swingle, Lauren Cressey, Richard A Heng

J Biol Chem· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-aryl-piperidine-4-carboxamides as a novel class of potent inhibitors of MALT1 proteolytic activity.
Achim Schlapbach, Laszlo Revesz, Carole Pissot Soldermann, Thomas Zoller, Catherine H Régnier, Richard Heng

Bioorg Med Chem Lett· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulating ADME Properties by Fluorination: MK2 Inhibitors with Improved Oral Exposure.
Juraj Velcicky, Achim Schlapbach, Richard Heng, Laszlo Revesz, Daniel Pflieger

ACS Med Chem Lett· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part I.
Laszlo Revesz, Achim Schlapbach, Reiner Aichholz, Roland Feifel, Stuart Hawtin, Richard Heng

Bioorg Med Chem Lett· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel 3-aminopyrazole inhibitors of MK-2 discovered by scaffold hopping strategy.
Juraj Velcicky, Roland Feifel, Stuart Hawtin, Richard Heng, Christine Huppertz

Bioorg Med Chem Lett· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrrolo-pyrimidones: a novel class of MK2 inhibitors with potent cellular activity.
Achim Schlapbach, Roland Feifel, Stuart Hawtin, Richard Heng, Guido Koch

Bioorg Med Chem Lett· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel CCR1 antagonists with oral activity in the mouse collagen induced arthritis.
Laszlo Revesz, Birgit Bollbuck, Thomas Buhl, Joerg Eder, Ronald Esser, Richard Heng

Bioorg Med Chem Lett· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New highly potent and selective adenosine A(3) receptor antagonists.
Neil J Press, Thomas H Keller, Pamela Tranter, David Beer, Ken Jones, Richard Heng

Curr Top Med Chem· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel Pd-catalyzed cyclization reaction of ureas for the synthesis of dihydroquinazolinone p38 kinase inhibitors.
Achim Schlapbach, Richard Heng, Franco Di Padova

Bioorg Med Chem Lett· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis